CARS1 and esophageal squamous cell carcinoma: After treatment with ferrostatin-1, a ferroptosis specific inhibitor, upregulated CARS1 remarkably enhanced the proliferation, migration and invasion in ESCC, diminished the MDA relative level and ROS content, and further enhanced GPX4 expression level.